SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-128797
Filing Date
2016-10-20
Accepted
2016-10-20 17:17:15
Documents
3
Period of Report
2016-10-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v450869_8k.htm 8-K 17473
2 EXHIBIT 99.01 v450869_ex99-01.htm EX-99.01 6569
3 GRAPHIC image_001.jpg GRAPHIC 73922
  Complete submission text file 0001144204-16-128797.txt   127080
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 161944896
SIC: 2834 Pharmaceutical Preparations